Market Access and Reimbursement Risk Assessment.
Built by former payers, HTA reviewers, and Industry Experts.
NICE: MARA rated targeted-release budesonide (Kinpeygo) A (Strong) before NICE published TA1128 on 4 February 2026. The A grade correctly predicted a positive access outcome — NICE recommended budesonide as
Link to the full report here 1. Executive Summary MARA Rating has completed a formal surveillance review of CagriSema (cagrilintide + semaglutide) following publication of Phase 3 head-to-head results versus
Executive Summary In February 2026, MARA published 37 rating actions. The month was notable not only for volume, but for compression of the rating profile into the lower-middle bands. One
MARA rated lecanemab (Leqembi) B++ (Marginal) before G-BA published Beschluss 7692 on 19 February 2026. The B++ grade correctly identified the marginal and uncertain zone — G-BA’s outcome of kein
MARA rated nivolumab (Opdivo) A (Strong) before NICE published TA1127 on 4 February 2026, recommending the drug for neoadjuvant plus adjuvant treatment of resectable NSCLC without EGFR or ALK alterations.
Executive Summary In January 2026, MARA issued nine initial reimbursement risk assessments across cardiology, infectious disease, neurology, oncology, obesity, and immunology. The monthly profile was concentrated in the middle of
Learn how MARA Rating’s Uncertainty & Sensitivity domain (A++–C) predicts HTA outcomes; why 2.6 vs 2.0 scores sway payer trust, pricing & reimbursement. Since 2020, we’ve seen a clear split:
How Evidence Quality Scores Impact HTA Assessment Success: The 2.9 Benchmark Since 2020, assets with an average Evidence Quality score of 2.9 have sailed through HTA assessments more regularly than
Many breakthrough therapies in the U.S. stumble in their first year on the market, despite strong clinical promise. The reason isn’t usually safety or efficacy. It’s cost pressures, evidence maturity, and system
About MARA Rating: We provide an independent Market‑Access Risk Assessment (A++ → C) built on a transparent, 10‑domain HTA framework. Use the score to benchmark an asset’s access prospects against